Article
NOSTRIN is an emerging negative regulator of decompensated cirrhotic patients with portal hypertension
2024-05-07
Abstract excerpt
<title>Abstract</title> <p><bold>Background and aims:</bold> Decreased nitric oxide (NO) bioavailability in a cirrhotic liver contributes to high intrahepatic vascular resistance (IHVR) and portal hypertension (PHT). Nostrin is an inhibitory protein of NO synthesising enzyme endothelial NO synthase (eNOS), shown to increase in cirrhosis with PHT, however, the precise molecular mechanism is poorly documented. This...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 6e532a54-d009-5a4a-b908-0528c0867b4b
- DOI
- 10.21203/rs.3.rs-4327525/v1
